Information Provided By:
Fly News Breaks for April 4, 2016
ELGX
Apr 4, 2016 | 06:31 EDT
JPMorgan analyst Michael Weinstein assumed coverage of Endologix with an Overweight rating and $11 price target following a period of restriction. The firm had an Overweight rating and $17 price target before the restriction.
News For ELGX From the Last 2 Days
There are no results for your query ELGX